Your Donations Matter

Friends of Prentice funds leading edge research that promotes superior healthcare spanning the arc of a woman's life.  By donating to Friends of Prentice you're supporting potentially life-saving initiatives, from Ovarian Cancer Detection to Postpartum Depression issues.  Your support is helping to ensure the highest quality of healthcare is delivered to women and infants in our immediate community and across the globe.
Over our 28 year history, FOP has funded many initiatives, including but not limited to those listed below.

 

$1.5M

Research in Prenatal Diagnosis

Friends of Prentice has established a $1.5 million endowment for the Friends of Prentice Fellowship in Maternal-Fetal Medicine.
Maternal-Fetal Medicine (MFM) specialists care for women experiencing precarious pregnancies. MFM specialists are obstetrician/gynecologists who have completed three years of formal fellowship education beyond their residency training. MFM specialists advance the knowledge of the obstetrical, medical, genetic and surgical complications of pregnancy, as well as the effects of such complications on both a pregnant woman and her developing fetus. The MFM Fellowship is one of only three in Illinois, and one of 63 programs around the nation.

$1.25M

Gynecologic Oncology Program

Overcoming cancers that attack women is a vital mission of Prentice Women's Hospital of Northwestern Memorial Hospital. In 2006, the Division of Gynecologic Oncology opened its first nine GOG trials. This translational research enables Northwestern to make innovative new treatment options available to patients in a safe and effective manner. It is the last phase of the research process and, therefore, is the vital link that brings new treatments into standard practice. By funding Northwestern Memorial's participation in the GOG trials, Friends of Prentice is facilitating the introduction of evidence-based therapies for women's cancers into widespread clinical practice.
Friends of Prentice funds have helped launch a groundbreaking, department-wide project on uterine fibroids, one of the most common and important public health problems, affecting 30 to 50 percent of reproductive-age women. They can cause excessive uterine bleeding, anemia, recurrent pregnancy loss and infertility.

$650K

National Ovarian Cancer Early Detection Program

The Northwestern Ovarian Cancer Early Detection and Prevention Program (NOCEDPP) provides focused, high quality care and services for over 1,100 participating women who have no current symptoms, but have an increased risk of developing ovarian cancer. Through the generous support from Friends of Prentice, a dedicated clinical research coordinator joined the comprehensive, expert clinical team of the NOCEDPP.
Research priorities within the NOCEDPP include the development of innovative new tests to help detect early stage ovarian cancercancer without relying on the CA-125 marker. CA-125 is a protein that can be a tumor marker made by abnormal ovarian cells. If it is present in high levels in the blood or in other body fluids or tissues, it may be a sign of ovarian cancer. Unfortunately, it is not an accurate marker for all types of ovarian cancers. Thus, this research has focused on identifying types of ovarian cancers for which CA-125 is not a reliable marker.

$500K

Patient and Physician Education

A grant of $500,000 established the Friends of Prentice Distinguished Physician in Women's and Infant's Health Program. This endowed appointment assists the hospital in recruiting and retaining the most eminent physicians in pediatrics, obstetrics and gynecology. The appointment, made by the president and chief executive officer of the hospital, honors an outstanding physician who has realized the highest personal and professional achievements in his or her field, including leadership in clinical practice and in the mentoring and training of residents and fellows.

$500K

The Institute for Women's health Research at Northwestern

A grant of $500,000 established the Friends of Prentice Distinguished Physician in Women's and Infant's Health Program. This endowed appointment assists the hospital in recruiting and retaining the most eminent physicians in pediatrics, obstetrics and gynecology. The appointment, made by the president and chief executive officer of the hospital, honors an outstanding physician who has realized the highest personal and professional achievements in his or her field, including leadership in clinical practice and in the mentoring and training of residents and fellows.

 

Our Recent History of Giving

Fiscal Year 2014
Grants Funding — $493,000

Nine projects funded including the areas of: Improved vascular developments in premature infants, biomarkers of inflammation of Perinatal depression, ovarian cancer treatments, reduction/prevention of uterine fibroids, maternal-fetal vitamin D deficiency & obesity onset linkage

Fiscal Year 2013
Grants Funding — $450,000

Eight projects funded including the areas of: MRI imaging and preventative therapy for cerebral palsy, sBPD (severe bronchopulmonary dysplasia) effects in pre-term infants, gynecological oncology clinical trials, primary and metastatic breast cancer treatments

Fiscal Year 2012
Grants Funding — $418,000

Five projects funded including the areas of: Stillbirth & genetic risk factors, endometriosis treatment, NICU cord blood study

See All